Glioblastoma Patient
In March 2025, feeling at the top of my physical and intellectual game, I played a game of pickleball, made coffee, had a seizure, and woke up in an MRI, shortly followed by a diagnosis of glioblastoma type 4. Yeah, the worst type of one of the worst cancers. I received excellent care from the team at UCSF and am undergoing the standard treatment, confident that such treatment helps, but perhaps not very much. I practice the basics (e.g., nutrition, sleep, mindfulness, exercise) but sad to say, such self-care did not prevent my cancer. Thus, I set forth on a quest for effective, complementary, clinical therapies.
At the time of writing, my quest remains arduous and dubious, what with the bewildering array of experimental treatments: some promising and very few for glioblastoma with clinical data. As a result, I applied my own filters: low downside risk, compelling theory of action, and trust in the provider. So far only one complementary therapy passed my filters: NKore’s. Why?
Low Downside Risk: A) NK cells rarely cause graft vs host disease, or cytokine storms. B) NKore does not use genetic engineering to target only one specific cancer marker; rather, NKore uses organic methods to activate the NK cells’ innate mechanism to attack all cancerous cells. “Targeted” may work on stable, homogeneous tumors, but shotgun blasts seem better for heterogeneous, shape-shifting cancers like mine.
Theory of action: A) NK cells cross the blood-brain barrier so could address my cancer. B) NKore uses cells from donors screened in advance to ensure they function well. This means NKore’s allogeneic NK cells (from external donors) may perform better than my own NK cells, which my cancer managed to elude. And D) NKore’s supercharged NK cells may live longer, with greater cancer-killing power, than NK cells used in other therapies I researched. NKore provided data (left) showing that my NK cells went from non-responsive to responding normally!
Trust: After six months of pesky due diligence, I developed confidence in the people at NKore. My clinical experience was first-class: clean facilities, knowledgeable and responsive clinicians, high attention to detail. And so far so good. Last word for today: to those of you with, or supporting someone with, cancer, I wish you heaps of positivity and courage.
